Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
For security purposes if you enter an incorrect password three consecutive times in the mobile app, your account will be locked for 30 minutes. During this time, you will not have access to your CGM data on the mobile app.
Your Eversense Inserter will explain and perform the simple and quick steps to remove the sensor. You will be fully awake during the approximately 5-minute removal procedure.
Step 1: Site preparation – the sensor site will be cleaned, disinfected, then anesthetized using lidocaine.
Step 2: Incision – a small (~ 5-6mm) incision will be made at the sensor site.
Step 3: Sensor removal – the sensor will be removed and discarded.
Step 4: Site closure – once removed, the incision will be closed with Steri-Strips™ (sutures may be used depending on provider’s preference).
The Glucose Statistics report shows your average, low and high glucose readings, along with standard deviation within 6 hour time periods. You can choose the last 1, 7, 14, 30 or 90 days.
The fluorophore will fluoresce when it binds to glucose. The amount of fluorescence directly corresponds to the amount of glucose in the interstitial fluid. If ambient light (like sunlight) is high enough to interfere with measuring that fluorescence, the system will display a High Ambient Light Alert. No glucose will be displayed until the condition is resolved by reducing the ambient light condition.
The proximity of the Eversense® E3 Sensor with medicated patches has not been studied. Please contact your health care professional for advisement.
The Eversense® E3 CGM System does has Predictive Alerts. To utilize this feature, you will need to turn it on in the App.
Predictive Alerts let you know in advance that a high or low glucose event is likely to occur if current trends continue.
Predictive Alerts use the Low and High Glucose Alert levels to provide an “early” warning. When you have reached the early warning time, the smart transmitter vibrates, and the mobile app gives an audible alert as well as displays a message on the screen. You should immediately perform a finger stick blood glucose test before making a treatment decision.
To turn this feature ON, tap Menu > Settings > Glucose to display the GLUCOSE SETTINGS screen.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
MKT-001692 Rev 1